IP Library Granted Patent US 8,293,630
Granted Patent B2
US 8,293,630 · App. 10/585,324 · Granted Oct 23, 2012

Material and method of fabrication therefor

Assignee: Psimedica Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,293,630
App. No.
10/585,324
Granted
Oct 23, 2012
Kind
B2
Abstract

The present invention concerns new methods of fabricating a silicon material comprising phosphorus. The methods allow high levels of phosphorus to be combined with the silicon. In one aspect of the invention a sample of phosphorus is surrounded with a sample of silicon. At least some of the phosphorus is then vaporised and caused to interact with the silicon.

Claims (12)

1. A method for producing a composite material comprising phosphorus and silicon, the method comprising the steps:

(a) taking a sample of phosphorus;

(b) substantially surrounding the sample of phosphorus with a layer of silicon, the layer of silicon comprising a multiplicity of silicon particles;

(c) applying heat to the silicon in such a manner that a temperature difference is established between at least part of the silicon layer and the sample of phosphorus, and in such a manner that at least some of the phosphorus is vaporised; and

(d) allowing and/or causing between 80% and 100% of the phosphorus vapour to contact at least part of the layer of silicon in such a manner that a molten composite material comprising silicon and phosphorus is formed.

2. A method according to claim 1 characterised in that steps (a), (b), and (c) are performed in such a manner that at least part of the silicon layer is heated to a silicon reaction temperature between 900 C and 1500 C.

3. A method according to claim 1 characterised in that the sample of phosphorus comprises red phosphorus.

4. A method according to claim 1 characterised in that method comprises the further step (e) of atomising at least part of the molten composite material generated by step (d).

5. A method according to claim 4 characterised in that the method comprises a further steps: (fi) of cooling and then (fii) porosifying at least some of the composite material formed by step (e).

6. A method according to claim 5 characterised in that the method comprises the further step (g) of irradiating at least some of the composite material produced by (fii) with neutrons in such a manner that at least some of the phosphorus is converted to 32 P.

7. A radiotherpeutic product obtainable by a method according to claim 6 .

8. A radiotherapeutic product according to claim 7 for use in the treatment of cancer.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2015
From: ENIGMA THERAPEUTICS LIMITED
To: ONCOSIL MEDICAL LTD
Reel/Frame 035128/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2013
From: PSIMEDICA LIMITED
To: ENIGMA THERAPEUTICS LIMITED
Reel/Frame 032070/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2006
From: DUNKLEY, JOHN JOSEPH; TELFORD, BRETT; CONNOR, STEPHEN EDWARD
To: PSIMEDICA LIMITED
Reel/Frame 018361/0213 →
Priority Claims (1)
GB 0400149.1 · Jan 6, 2004 · national
Continuity (1)
Related Publication 20070190761A1 · Aug 16, 2007